NCT05237960: Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia |
|
|
| Recruiting | 2 | 86 | Canada, US | Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Extended Release Metformin Hydrochloride, ER Metformin Hydrochloride, Extended-release Metformin Hydrochloride, Glucophage XR, Glumetza, Metformin Hydrochloride Extended Release, Placebo Administration | University of Arizona, National Cancer Institute (NCI) | Erythroplakia, Oral Leukoplakia | 08/26 | 08/28 | | |